VBI Vaccines Profile

4.1
USD 0.25  6.49%
3.85Last Month High 5.03 
3.97Trading Day  High 4.2 

Purchase by Jeff Baxter of 15000 shares of VBI Vaccines

VBI Vaccines Inc insider trading alert for perchase of common shares no par value per share by Jeff Baxter, CEO President, on November 29, 2017. This event was filed by Vbi Vaccines Inc with SEC on 2017-11-29. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

VBI Vaccines Summary

VBI Vaccines Inc (VBIV) is traded on Nasdaq Capital Markets in USA. It is located in MASSACHUSETTS, U.S.A and employs 18 people. VBI Vaccines is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 164.94 M. VBI Vaccines Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 40.23 M outstanding shares of which 653.63 K shares are at this time shorted by private and institutional investors with about 1.91 trading days to cover. VBI Vaccines Inc. currently holds about 10.05 M in cash with (29.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.
Check VBI Vaccines Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected VBI Vaccines Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

VBI Vaccines Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 90% 
VBI Vaccines Inc., a commercial stage biopharmaceutical company, develops vaccine candidates and novel technology platforms in Israel and internationally. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameVBI Vaccines Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
LocationMASSACHUSETTS, U.S.A
Business AddressCambridge, MA
ExchangeNasdaq Capital Markets
CUSIPNone
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.scivactherapeutics.com
Contact Number617 830 3031
CurrencyUSD - US Dollar

Recommendations

VBI Vaccines Analyst Recommendations
Target PriceAdvice# of Analysts
8.5Strong Buy2Odds
VBI Vaccines Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
VBI Vaccines Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

VBI Vaccines Earnings Estimates
VBI Vaccines Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate